ALB and Familial prostate cancer: When we individually analyzed 8 episodes of major bleeding with rivaroxaban in our study population we found out they were mainly in older population i.e. aged 65 years or higher with poor nutritional reserve i.e. low albumin, BMI less than 22 and had an advanced metastatic breast or prostate cancer.